Intranasal heparin reduces eosinophil recruitment after nasal allergen challenge in patients with allergic rhinitis

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 5, 2001, Pages 703-708

  Vancheri, Carlo ^a   Mastruzzo, Claudio ^a   Armato, Ferdinando ^a   Tomaselli, Valerio ^a   Magr, Salvatore ^a   Pistorio, Maria Provvidenza ^a   LaMicela, Maria ^a   D'Amico, Leda ^a   Crimi, Nunzio ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Allergy; ECP; Eosinophils; Heparin; Nasal lavages; Rhinitis

Indexed keywords

ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; EPARINA VISTER; HEPARIN; PLACEBO;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EOSINOPHIL; FEMALE; HUMAN; INFLAMMATION; LAVAGE; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0035177654     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.118785     Document Type: Article

References (36)

1. The effect of heparin and related proteoglycans on allergen and PAF-induced eosinophil infiltration
2. Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation
3. Suppression by intradermal administration of heparin of eosinophil accumulation but not oedema formation in inflammatory reactions in guinea-pig skin
4. Inhibition of T lymphocytes heparanase by heparin prevents T cell migration and T cell-mediated immunity
5. Importance of 6-O-sulfate groups of glucosamine residues in heparin for activation of FGF-1 and FGF-2
6. 1
7. Inhibition of rat cervical epithelial cell growth by heparin and its reversal by EGF
8. The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis
9. Inhibition of complement dependent experimental inflammation in human skin by different heparin fractions
10. Effects of inhaled heparin on immunologic and non-immunologic bronchoconstrictor responses in sheep
11. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects
12. Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma
13. Time course of the protective effect of inhaled heparin on exercise-induced asthma
14. Preventing bronchoconstriction in exercise-induced asthma with inhaled heparin
15. 3-mediated mast cell degranulation
16. Time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled heparin in allergic asthma
17. Immunologic mast cell- mediated responses and histamine release are attenuated by heparin
18. Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarine M2 receptor
19. The effect of inhaled heparin and related glycosaminoglycans on allergen-induced eosinophil infiltration in guinea-pigs
20. Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge
21. Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis
22. The influx of inflammatory cells into nasal washings during the late response to antigen challenge
23. The cellular basis for allergic rhinitis
24. In vitro studies of the interaction between heparin and eosinophil cationic protein
25. Anti-inflammatory treatment of asthma: Current deficiencies in therapy
26. Therapeutic uses of heparin beyond its traditional role as an anticoagulant
27. Effect of heparin on antigen-induced airway responses and pulmonary leukocyte accumulation in neonatally immunized rabbits
28. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis
29. Regulation of proinflammatory cytokines in seasonal allergic rhinitis
30. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression
31. Histamine augments VCAM-1 expression on IL-4 and TNF-alpha-stimulated human umbilical vein endothelial cells
32. Leukotriene C4/D4 induces P-selectin and sialyl Lewis(x)-dependent alterations in leukocyte kinetics in vivo
33. Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism
34. Heparin-like glycosaminoglycans inhibit leukocyte adhesion to endotoxin-activated human vascular endothelial cells under nonstatic conditions
35. Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix
36. Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions